---  
layout: startup_page  
title: "Paradox Immunotherapeutics"  
id: "paradoximmuno.com"  
permalink: "/paradoximmunotherapeuticsparadoximmuno.com02252025/"  
website: "https://www.paradoximmuno.com"  
funding_round: ""  
funding_amount: "$10M"  
investors: "SymBiosis"  
about: "Paradox Immunotherapeutics is a preclinical-stage biotech company focused on developing innovative antibody therapies to treat protein misfolding diseases, such as amyloidosis. Their approach involves using a unique platform to develop antibodies that selectively target misfolded proteins while leaving healthy proteins untouched. The company is developing treatments for immunoglobulin light chain amyloidosis and leukocyte chemotactic factor 2 amyloidosis."  
markets: "Biotech, Pharmaceuticals"  
hq: "Toronto, Ontario, Canada"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/paradoximmuno/"  
twitter: "https://twitter.com/ParadoxImmuno"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/paradox-immunotherapeutics-inc"  
pitchbook: "https://pitchbook.com/profiles/company/483450-94"  

date_display: "25-Feb-2025"  
date: "2025-02-25"

# SEO Optimization  
meta_title: "Paradox Immunotherapeutics -  Funding ($10M)"  
meta_description: "Paradox Immunotherapeutics, Paradox Immunotherapeutics is a preclinical-stage biotech company focused on developing innovative antibody therapies to treat protein misfolding dise..."  
meta_keywords: "Paradox Immunotherapeutics, Biotech, Pharmaceuticals,  funding"  
canonical_url: "https://startup.projectstartups.com/paradoximmunotherapeuticsparadoximmuno.com02252025/"  
---